7th to 11th November 2016, Oxford, United Kingdom.
The Biological Therapeutics short course will focus on emerging areas of medicine using nucleic acids as drugs and also using treatments based on stem cells and bioengineered tissues, including the combined technologies reflecting uses of genetically modified stem cells. Starting from well established fields such as bone marrow transplantation for treatment of immune deficiency and cancer, we will assess range of emerging therapeutic approaches building on the use of human adult, cord blood and embryonic stem cells and will discuss the possibilities of nuclear transfer and iPS cells. Current technologies for growing stem cells in culture and organ engineering will also be assessed. This part of the module will culminate in studies using genetically modified (autologous) bone marrow stem cells to treat immune deficiency patients without matched donors, using retroviruses and latterly lentiviruses to achieve long term expression of therapeutic transgenes within the bone marrow.
The course will cover the following topics:
- Different approaches to gene therapy
- RNA therapeutics
- Antibody based therapeutics
- Stem cell based treatments and immunotherapies
- Cancer biology and microenvironment
- Cancer immunology and vaccines
- Viral vectors for gene therapy
- Clinical trial design for vaccines and gene therapy
Find more information on the course here.
Published in GI-Mail 10/2016 (English edition). Sign up for GI-Mail here. 
Tip: More up to date educational events can be found online in the Education Database »medicine & health«.
